← All companies

OLMA

Olema Pharmaceuticals, Inc.

OLMA Nasdaq Pharmaceutical Preparations EDGAR ↗

$11.28

-0.17 -1.48%

Key statistics

from XBRL data in SEC filings

Market cap

$985M

Revenue (TTM)

—

Net income (TTM)

-$185M

EPS (TTM)

$-2.03

P/E ratio

—

Dividend yield

—

Free cash flow

-$147M

Cash

$52.5M

Total assets

$531M

Gross margin

—

52-week range

$4.47 – $36.26

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 23, 2026 8-K Regulation FD disclosure; Other events May 26, 2026 8-K Regulation FD disclosure; Other events May 21, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Entered a material agreement; Took on a direct financial obligation May 1, 2026 8-K Director or officer change; Regulation FD disclosure Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Mar 16, 2026 8-K Results of operations (earnings release) Mar 16, 2026 8-K Director or officer change Jan 30, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 12, 2026 8-K Other events Nov 19, 2025 8-K Other events Nov 18, 2025 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure; Other events Oct 20, 2025 8-K Regulation FD disclosure; Other events Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 11, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 11, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Results of operations (earnings release) Mar 18, 2025 8-K Regulation FD disclosure Mar 5, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Unregistered sale of equity Jan 10, 2025 8-K Regulation FD disclosure; Other events Dec 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Regulation FD disclosure; Other events Sep 27, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 2, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Regulation FD disclosure; Other events May 15, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024